342 related articles for article (PubMed ID: 21862776)
1. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.
Kawamoto S; Shi C; Hruban RH; Choti MA; Schulick RD; Fishman EK; Siegelman SS
AJR Am J Roentgenol; 2011 Sep; 197(3):W482-8. PubMed ID: 21862776
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production?
Shi C; Siegelman SS; Kawamoto S; Wolfgang CL; Schulick RD; Maitra A; Hruban RH
Radiology; 2010 Oct; 257(1):107-14. PubMed ID: 20713615
[TBL] [Abstract][Full Text] [Related]
3. Serotonin-positive neuroendocrine neoplasm with pancreatic ductal dilation in which cytological immunostaining contributed to the diagnosis.
Ariga H; Kashimura J; Horigome Y; Okada K
Clin J Gastroenterol; 2022 Aug; 15(4):822-825. PubMed ID: 35471694
[TBL] [Abstract][Full Text] [Related]
4. Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement.
McCall CM; Shi C; Klein AP; Konukiewitz B; Edil BH; Ellison TA; Wolfgang CL; Schulick RD; Klöppel G; Hruban RH
Hum Pathol; 2012 Aug; 43(8):1169-76. PubMed ID: 22221702
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Duct Involvement in Well-Differentiated Neuroendocrine Tumors is an Independent Poor Prognostic Factor.
Nanno Y; Matsumoto I; Zen Y; Otani K; Uemura J; Toyama H; Asari S; Goto T; Ajiki T; Okano K; Suzuki Y; Takeyama Y; Fukumoto T; Ku Y
Ann Surg Oncol; 2017 Apr; 24(4):1127-1133. PubMed ID: 27822631
[TBL] [Abstract][Full Text] [Related]
6. Multiple solid pancreatic lesions: Prevalence and features of non-malignancies on dynamic enhanced CT.
Zhu L; Dai MH; Wang ST; Jin ZY; Wang Q; Denecke T; Hamm B; Xue HD
Eur J Radiol; 2018 Aug; 105():8-14. PubMed ID: 30017302
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Non-Functioning Pancreatic Neuroendocrine Tumor Accompanied by Stenosis of the Main Pancreatic Duct].
Ishii T; Nakamura N; Saitou T; Yonekura K; Watanabe Y; Sanada T; Kuwabara H; Goseki N; Koike M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1632-1634. PubMed ID: 29394725
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous fine-needle aspiration cytologic study of main pancreatic duct stenosis under pancreatographic guidance.
Gagnon P; Boustiere C; Ponchon T; Valette PJ; Genin G; Labadie M
Cancer; 1991 May; 67(9):2395-400. PubMed ID: 2013042
[TBL] [Abstract][Full Text] [Related]
9. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
Li JK; Wang M; Yuan J; Song ZG
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
[No Abstract] [Full Text] [Related]
10. CT imaging spectrum of pancreatic serous tumors: based on new pathologic classification.
Sun HY; Kim SH; Kim MA; Lee JY; Han JK; Choi BI
Eur J Radiol; 2010 Aug; 75(2):e45-55. PubMed ID: 20056368
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics.
Raman SP; Hruban RH; Cameron JL; Wolfgang CL; Fishman EK
AJR Am J Roentgenol; 2012 Aug; 199(2):309-18. PubMed ID: 22826391
[TBL] [Abstract][Full Text] [Related]
12. A small pancreatic hamartoma with an obstruction of the main pancreatic duct and avid FDG uptake mimicking a malignant pancreatic tumor: a systematic case review.
Nagano H; Nakajo M; Fukukura Y; Kajiya Y; Tani A; Tanaka S; Toyota M; Niihara T; Kitazono M; Suenaga T; Yoshiura T
BMC Gastroenterol; 2017 Dec; 17(1):146. PubMed ID: 29212451
[TBL] [Abstract][Full Text] [Related]
13. Natural History of Pancreatic Duct Obstruction by a Pancreatic Neuroendocrine Tumor.
Thomas AS; Luk L; Chabot JA
J Gastrointest Surg; 2022 Jun; 26(6):1340-1341. PubMed ID: 35083721
[No Abstract] [Full Text] [Related]
14. Assessment of pancreatic duct strictures.
Jowell PS
Gastrointest Endosc Clin N Am; 1995 Jan; 5(1):125-43. PubMed ID: 7728341
[TBL] [Abstract][Full Text] [Related]
15. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic ultrasound appearance of pancreatic serotonin-staining neuroendocrine neoplasms.
Massironi S; Partelli S; Petrone MC; Zilli A; Conte D; Falconi M; Arcidiacono PG
Pancreatology; 2018 Oct; 18(7):792-798. PubMed ID: 30115562
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography of the normal and abnormal pancreatic duct: correlation with pancreatic ductography.
Berland LL; Lawson TL; Foley WD; Greenen JE; Stewart ET
Radiology; 1981 Dec; 141(3):715-24. PubMed ID: 7302228
[TBL] [Abstract][Full Text] [Related]
18. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
[TBL] [Abstract][Full Text] [Related]
20. Serotonin immunoreactivity in pancreatic endocrine neoplasms (carcinoid tumors).
Wilson RW; Gal AA; Cohen C; DeRose PB; Millikan WJ
Mod Pathol; 1991 Nov; 4(6):727-32. PubMed ID: 1788265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
